Prodia Diagnostic Line Tbk vs Sinergi Multi Lestarindo Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp177 (market cap 414.41B, 19.89M 24h volume). The key difference: Prodia Diagnostic Line Tbk and Sinergi Multi Lestarindo Tbk. are close in size by market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 19.89M). Which is the better fit depends on your goals.
| PRDL | SMLE | |
|---|---|---|
Market Cap | 470.58B | 414.41B |
Volume | 28.43M | 19.89M |
Lot | 284.34K | 198.86K |
Turnover | 7.8B | 3.5B |
Average Price | 274.19 | 176.21 |
Value | 7.8B | 3.5B |
Indicative Equilibrium Price | 270 | 184 |
Indicative Equilibrium Volume | 2.1K | 1.71K |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →